Emmanuelle Charpentier

Emmanuelle Charpentier is joining the Max Planck Institute for Infection Biology on Oct. 1 as scientific director, where she will set up a new department within the institute. She is a co-inventor of the CRISPR/Cas9 genome editing technology. Charpentier has been a professor at the Helmholtz Centre for Infection Resarch and Hannover Medical School and at the Laboratory for Molecular Infection Medicine at Umeå University.